Silver has been rising because it is caught in a rare sweet spot: a “green-tech” industrial metal in structural shortage that investors suddenly remembered is also money. Add in geopolitical jitters, fading real yields, and a mining sector that has underinvested for…
Biopharma spent 2025 behaving like a sector that has finally read the fine print on the cost of capital—and decided to let someone else pick up the bar tab. Licensing and M&A stepped into the role IPOs used to play, and did…
Wall Street stumbled on Tuesday as investors tried to handicap tariffs, the Fed and Washington all at once, leaving the major indexes split between old‑economy resilience and growth‑stock vertigo.
Indexes: Value Holds Its Nerve
The S&P 500 slid roughly 2.06% on the day, marking…
GSK’s move to acquire RAPT Therapeutics for $2.2 billion reads like the opening chapter of 2026’s biotech M&A season: rich valuation, strategic fit, and just enough risk to keep the buy-side awake. It is also an early signal that Big Pharma’s deal…
America is racing to build the AI future, but Ford’s Jim Farley is warning that the country may run out of people to pour the concrete, pull the cable, and keep the servers humming long before it runs out of capital. At…
U.S. stocks drifted lower in this week, as investors digested early fourth‑quarter earnings, stubbornly mixed inflation data, and a Treasury market that seems determined to remind everyone that “higher for longer” is still a thing, even if no one wants to RSVP.…
Anthropic’s decision to tap Microsoft veteran Irina Ghose as its Managing Director for India reads less like a routine executive shuffle and more like a signal flare from the frontier of AI competition—Bengaluru is about to get a new large‑language landlord.
A…
Wall Street ended Wednesday with big tech nursing a hangover, small caps stealing the limelight, and investors once again discovering that the yield curve has a better sense of drama than most streaming services.
Indexes: Big Tech Blinks, Small Caps Smirk
The Nasdaq…
U.S. stocks slipped modestly on Tuesday as Wall Street digested a cooler core inflation print, a heavy dose of bank earnings, and fresh tariff salvos from Washington, leaving the major indexes just a step back from record territory rather than in full…
Wall Street kicked off the week in an ebullient mood Monday, as major U.S. equity benchmarks climbed to fresh heights while gold and silver behaved like they had just discovered caffeine
Indexes: Bulls in Full Voice
The S&P 500 added roughly 0.2%–0.3%, extending last…
